Applications of Methyl L-Phenylalaninate Hydrochloride in Industrial Manufacturing

Methyl L-Phenylalaninate Hydrochloride serves as a specialized raw material in several industrial sectors, each governed by distinct regulatory and process demands. Our chemical integration experience supports customers in pharmaceuticals, peptide synthesis, research reagents, and chiral intermediates production. Below, we detail core downstream uses, standards, ratios, integration steps, and typical product outputs tailored precisely to real-market manufacturing.

1. Active Pharmaceutical Ingredient (API) Intermediate in Antihypertensive Drug Synthesis

API manufacturers deploy this raw material as a building block during the synthesis of key antihypertensive drug molecules, such as angiotensin receptor blockers. The compound’s chiral purity and salt form guarantee precise reactions during stepwise coupling and deprotection processes, critical for compliance with pharmaceutical-grade consistency. Custom batch sizes and solution/solid-phase processes accommodate both small-molecule and large-scale medicinal pipelines with established GMP protocols.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP-NF and Ph. Eur. relevant monographs for process intermediates
• 21 CFR Part 210/211 (US FDA), EudraLex Volume 4 (EU GMP Guide)
• ISO 9001:2015 for Quality Management Systems in pharmaceutical production

Typical usage ratio

• 0.95–1.05 molar equivalence within the condensation step, depending on side-chain protection and target API yield
• Minor adjustments based on stoichiometric balance of halide, ester, or protected acid functionality

Downstream process integration

• Enters post-protection amino acid coupling for API core structure assembly
• Chiral column purification and subsequent deprotection steps prior to final formulation
• Real-time release testing at intermediate stage before API condensation

Final product types

• Finished tablets and capsules containing antihypertensive APIs
• Injectable solutions for clinical hypertension management

2. Protected Amino Acid for Peptide Synthesis (Solid-Phase and Solution-Phase)

Peptide contract manufacturers and research labs incorporate this material as a protected amino acid during both solid-phase and solution-phase peptide synthesis. Its stable methyl ester group allows selective deprotection after core peptide bond formation, supporting sequence-specific assembly without undesired racemization. Peptide chains assembled with this intermediate meet purity and performance requirements for diagnostic, therapeutic, and analytical reagent production.

Industry compliance standards

• USP General Chapter <1047> "Peptide APIs"
• EP 2034 "Peptides for pharmaceutical use"
• GMP Guidelines for Peptide Production (ICH Q11)
• ISO 13485 for medical devices reagents (where applicable)

Typical usage ratio

• 1.00–1.10 molar input per amino acid residue coupled; excess ensures full conversion on resin
• Ratio modulated by sequence length and resin substitution degree

Downstream process integration

• Preloaded or manually added to automated peptide synthesizer reactors
• Participates in N-terminal extension and iterative chain elongation via amide bond formation
• Deprotection and resin cleavage post-assembly, followed by RP-HPLC purification

Final product types

• Custom peptides for pharmaceutical research and clinical trials
• Peptide reference standards for analytical labs
• Functionalized peptides for immunoassay kits

3. Chiral Intermediate for Agrochemical Synthesis

Agrochemical formulators utilize the compound to introduce specific chirality during the multi-step synthesis of active crop protection agents. The hydrochloride form protects functional groups during condensation, ensuring controlled release and minimal impurity formation. This function proves essential in manufacturing herbicides and insecticides with regulatory-mandated chiral purity targets, minimizing environmental persistence and maximizing field effectiveness.

Industry compliance standards

• FAO/WHO specification for active ingredient identity and enantiomeric purity
• REACH Regulation (EC) No 1907/2006 for chemical safety in EU agrochemical production
• ISO 9001:2015 for agrochemical quality systems

Typical usage ratio

• 0.8–1.2 molar equivalence relative to target chiral intermediate, optimized for impurity profile and yield
• Adjusted depending on downstream cyclization or hydrolysis efficiency

Downstream process integration

• Feeds directly into enantioselective condensation or alkylation steps
• Chiral auxiliary removed in mid-stage synthesis to recover free base for next reaction
• Integrated with solvent extraction and crystallization prior to formulation for field use

Final product types

• Intermediate concentrates for selective herbicide products
• Bulk technical-grade insecticide compounds

4. Building Block in Chiral Fine Chemical Production

Chemical manufacturers adopt this ester as a stereocontrolled building block for the assembly of custom chiral auxiliaries, ligands, and fine chemicals vital to asymmetric synthesis platforms. The material’s hydrochloride protection simplifies downstream functionalization without undesired racemization, ensuring product line consistency for advanced catalysts and specialty monomers.

Industry compliance standards

• ISO 9001:2015 quality management in fine chemicals
• Internal QA/QC protocols—HPLC, chiral GC, and NMR—benchmarked to international best practices
• Responsible Care® management systems for environmental and safety compliance

Typical usage ratio

• 1.00–1.20 molar equivalents, tailored to downstream chiral modification, depending on target product structure
• Process-specific based on desired auxiliary or ligand complexity

Downstream process integration

• Feeds into amidation, alkylation, and esterification for downstream ligand/catalyst synthesis
• Chiral purity verified by direct chiral HPLC and NMR after key modification steps
• Used in batch and continuous-flow synthesis skids

Final product types

• Optically pure chiral auxiliaries for asymmetric catalysis
• Fine chemicals for polymer modification and specialty monomer supply chains

5. Research-Grade Reagent for Analytical and Structural Biology Studies

Academic and industrial R&D facilities employ this hydrochloride salt as a standard reagent for chirality verification, protein engineering, and structural analysis. Its defined purity and distinctive protected form offer reliable performance in developing analytical standards and calibrating chiral detectors, including NMR and mass spectrometry studies focused on structure–activity relationships or protein–ligand binding assays.

Industry compliance standards

• ISO/IEC 17025 laboratory accreditation guidance
• GLP (Good Laboratory Practice) for research reagent preparation (OECD Principles)
• Analytical reagent grade (ARG) specification

Typical usage ratio

• Stock solutions at 1–10 mmol/L; working concentration depends on assay, optimized for calibration and spike controls
• Microgram to milligram scale for analytical methods development

Downstream process integration

• Dissolved as reference standard for chiral chromatographic and spectrometric calibration curves
• Used as standard substrate or ligand analog for binding studies in biophysical assays
• Entrusted in method validation and internal cross-checking routines

Final product types

• Analytical standards for chiral column calibration and quality control
• Reference compounds in NMR, MS, and protein binding studies